agents © Pimodivir'
e Umifenovir

e adamantane derivatives/M2 inhibitors (Adapromine
Amantadine
Rimantadine)

neuraminidase inhibitors/release phase (Oseltamivir®
Zanamivir

Peramivir, Laninamivir")
e Interferon alfa 2b
Interferon e Peginterferon alfa-2a"

e Peginterferon alfa-2b*

e EICARS
e Favipiravir
e Galidesivirt
Multiple/genera ° Remdesivir’
l © Mericitabine’
Multiple/unknow e MK-6088
n e NITDOOSS
e Moroxydine
e Presatovir’
e Ribavirin®
e Taribavirin’
e Triazavirin
e “WHO-EM
e ‘Withdrawn from market
e Clinical trials:

o ‘Phase III
o ‘Never to phase III
show

ev
et
ee
Filoviridae
e Bundibugyo ebolavirus

o BDBV
Ebolavirus Species

e Reston ebolavirus

o RESTV

NIH-000301
